P3 Health Partners Raises 2026 Adjusted EBITDA Guidance to $90M-$110M
P3 Health Partners (PIII) has updated its financial outlook, raising the lower end of its full-year 2026 adjusted EBITDA guidance. The company reported a Q3 adjusted EBITDA of $21 million, bringing its year-to-date total to $101 million. The management team is currently targeting $200 million in value creation as part of its long-term strategic goals. This upward revision reflects the company's ongoing efforts to optimize operational performance and strengthen its financial position.
Topics: adjusted EBITDA earnings financial guidance
Read the full article at Seeking Alpha
Part of the story P3 Health Reports Q3 2026 Profitability Turnaround and Increased Full-Year Guidance (7 articles)